Attorney Jessica Paluch-Hoerman, founder of TruLaw, has over 28 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.
This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.
TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.
Question: What is the Transvaginal Mesh Lawsuit?
Answer: Transvaginal mesh lawsuits have been filed nationwide by women who claim that defective surgical mesh implants caused severe health complications, such as recurring infections, organ perforation, and internal bleeding that often required patients to endure multiple revision surgeries.
On this page, we will provide an overview of the transvaginal mesh lawsuit, eligibility criteria to file a transvaginal mesh lawsuit, types of damages cause by surgical mesh, and much more.
The lawsuits center on serious design defects in transvaginal mesh products that made them inherently dangerous for patients by degrading inside the body over time, becoming rigid, and harboring harmful bacteria due to their porous design.
Legal experts are investigating the adequacy of these manufacturers’ design and testing practices following the FDA’s issuance of multiple safety warnings and re-classification of transvaginal mesh products in 2016.
While many cases have been resolved, individual claims can still be filed today.
If you or someone you love has experienced complications with your transvaginal mesh implant, you may be eligible to seek compensation.
Contact TruLaw using the chat on this page to receive an instant case evaluation that can determine if you qualify to join others in filing a transvaginal mesh lawsuit.
Our transvaginal mesh attorney at TruLaw is dedicated to supporting clients through the process of filing a defective medical device lawsuit.
With extensive experience in handling similar cases, Jessica Paluch provides personalized support and advocacy to clients seeking the compensation they deserve.
We understand the challenges and emotional toll that transvaginal mesh complications can bring, and we are committed to simplifying the legal process for you.
Meet our lead transvaginal mesh attorney:
At TruLaw, we believe that financial concerns should never stand in the way of seeking justice.
That’s why we operate on a contingency fee basis—a system designed to align our success with yours.
With this approach, you won’t face any upfront costs when hiring our attorney.
Our fees are only collected if we are successful in securing compensation on your behalf.
This arrangement not only removes the financial risk of pursuing your case, it allows us to focus our resources on achieving a positive outcome in your case by:
If you or someone you love has experienced serious side effects from Depo-Provera, you may qualify to seek compensation.
Contact TruLaw using the chat on this page to receive an evaluation of your claim and determine your eligibility to join others in filing a transvaginal mesh lawsuit today.
The use of vaginal mesh has been a significant medical development, originally introduced as a solution for pelvic organ prolapse (POP) and stress urinary incontinence (SUI) in women, particularly those who have undergone childbirth.
Synthetic meshes were adopted for such surgeries in the 1990s, experiencing widespread use thanks to their success in hernia repairs.
However, issues began to arise as many women reported severe and chronic complications, such as nerve damage and persistent pain.
As controversies grew, transvaginal mesh procedures were heavily scrutinized, eventually leading the FDA to mandate more stringent evaluations and eventually ban the use of these meshes in certain procedures by 2019.
The development of vaginal mesh technology primarily aimed to improve outcomes for women undergoing surgery for pelvic organ prolapse (POP) and stress urinary incontinence (SUI).
Initially, both biological and synthetic grafts were explored, with synthetic materials gaining traction in the 1990s due to their successful application in hernia repair surgeries.
Vaginal mesh, introduced in the late 1990s, promised to provide durable support for the vaginal structure, reducing the recurrence rate of these conditions.
Over time, surgical mesh became a routine choice for these procedures, driven by evidence suggesting better durability and efficacy when compared to tissue repair alone.
Key historical milestones in vaginal mesh development include:
Despite their initial promise, vaginal meshes developed complications and safety became a significant concern.
The rigid synthetic materials sometimes led to severe side effects, notable among them being chronic pain, erosion of the mesh into surrounding tissues, and infections.
The rate and severity of these complications resulted in heightened public and regulatory scrutiny, leading to the FDA’s involvement and decision to require stricter clinical trials and follow-up studies.
This regulatory shift marked a turning point in how transvaginal mesh products were developed and deployed in medical practice.
Concerns about vaginal mesh complications emerged not long after their introduction, as early adopters began reporting adverse symptoms.
Problems like mesh erosion, where the mesh protrudes into the vaginal wall or other organs, were alarmingly frequent.
Women experienced chronic pain, infections, and sometimes debilitating pelvic floor muscle issues, necessitating further surgeries.
Such reactions prompted medical practitioners to question the safety profile of these devices, thereby beginning a closer evaluation of their risks versus benefits.
Common early complications associated with vaginal mesh include, but are not limited to:
These complications led to increased awareness and eventual legal action against mesh manufacturers.
Patients sought legal recourse due to the lack of adequate warnings and labeling about potential side effects.
Surgeons and medical experts highlighted the need for improved patient education on the risks of mesh implantation.
Over time, this advocacy and documentation of adverse effects influenced healthcare policy, culminating in stern regulatory actions and a significant number of lawsuits from affected patients.
Vaginal mesh, primarily used in surgeries for pelvic organ prolapse and stress urinary incontinence, has been linked to significant complications, triggering numerous lawsuits.
The complications related to these implants have resulted in over 100,000 lawsuits, many of which have been resolved by settlements.
Despite the initial purpose of these medical devices to support weakened pelvic tissue, they often lead to more harm than benefit due to adverse effects such as erosion, pain, and infection.
This situation underscores the importance of understanding both the immediate and long-term risks involved with these devices.
Vaginal mesh implants are associated with several adverse effects, many of which contribute to significant patient discomfort and serious health issues.
The most commonly reported problems include mesh erosion or exposure, which can lead to infection or additional surgical interventions.
Patients often experience chronic pain, bleeding, and organ perforation, all contributing to a decreased quality of life.
Due to these complications, the use of vaginal mesh has become a subject of scrutiny, and patients are seeking legal recourse for these injuries.
Potential complications observed in patients may include:
These complications often necessitate further medical procedures to address the issues caused by the initial implantation of the mesh.
Corrective surgeries not only aim to manage the adverse effects but also strive to restore the quality of life for the affected individuals.
However, the risk of recurrent complications persists even after medical interventions.
Many patients end up suffering long-term physical and emotional distress, which underscores the gravity of these adverse effects.
The long-term consequences of vaginal mesh implantation can be profound and far-reaching, affecting many aspects of a patient’s life.
Over time, patients have reported issues such as chronic pain, urinary problems, and psychological distress stemming from their initial surgery.
These problems can develop as a result of the mesh degrading or causing ongoing reactions with the body’s tissues.
This potential for adverse long-term outcomes was a significant factor in the flood of lawsuits filed by affected patients.
Long-term consequences often highlighted in legal cases include:
Managing these long-term consequences often requires a multi-disciplinary approach involving surgical, psychological, and physical therapies.
The chronic nature of some of these conditions can lead to ongoing medical treatment and significant financial and emotional burdens for patients.
The high volume of litigation reflects a growing awareness and acknowledgment of the severe and lasting impacts of vaginal mesh implantation.
Addressing these issues requires concerted efforts from medical practitioners, regulatory bodies, and legal systems to better protect patients in the future.
In 2025, regulatory actions concerning transvaginal mesh continued to focus on ensuring patient safety and awareness of potential risks.
The FDA has played a crucial role in classifying and issuing warnings about the use of transvaginal mesh, owing to complications and injuries reported over the years.
This has led to increased scrutiny and a push for more stringent regulations to manage the risk associated with these medical devices.
Simultaneously, public awareness and concern have grown, partially due to media coverage that highlights the ongoing legal battles and substantial settlements awarded to affected women.
The combination of regulatory oversight and public discourse underscores the significant impact of transvaginal mesh issues on both the legal and healthcare landscapes.
The FDA has consistently issued warnings and safety alerts regarding transvaginal mesh due to the significant number of complications associated with its use.
Over time, the FDA has reclassified vaginal mesh devices to reflect their high-risk nature, mandating stringent controls and premarket approval.
This heightened regulatory oversight highlights the associated risk factors, such as erosion, pain, and infection, that have been reported by many women.
In recent years, there have been calls for comprehensive evaluations before their commercial release to mitigate adverse outcomes, exemplifying a shift towards more cautious medical device governance.
FDA regulatory actions to mitigate risks may include, but are not limited to:
These measures are intended to enhance patient safety and ensure that only thoroughly evaluated products are available on the market.
The FDA’s stringent approach aims to reduce the incidence of adverse events by fostering a robust regulatory framework.
This has encouraged manufacturers to develop safer alternatives and emphasizes the importance of informed patient consent.
Through continued vigilance and responsive measures, the FDA strives to protect public health while supporting innovation in medical devices.
Public awareness of transvaginal mesh complications has increased substantially, largely driven by extensive media coverage and the dissemination of lawsuit verdicts.
Many media outlets have highlighted the plight of affected women, showcasing stories of significant physical and emotional distress.
Such coverage has amplified public concern, prompting many to call for greater transparency and stricter regulations from healthcare providers and device manufacturers.
The overlap of legal issues with everyday healthcare experiences has led to a broader discourse around medical accountability and patient rights.
Key factors contributing to public concern typically include:
The public’s growing concern underscores the importance of effective communication between healthcare providers and patients regarding the risks and benefits of medical devices.
It also spotlights the media’s role in influencing public perception and holding entities accountable for their actions.
This collective awareness and advocacy can potentially catalyze change, leading to improved medical standards and practices.
As the conversation around transvaginal mesh continues, it becomes increasingly clear that informed patient choices and robust regulatory systems are crucial to fostering trust in healthcare.
In 2025, transvaginal mesh lawsuits continue to be a significant legal avenue for those who have suffered from complications due to these medical devices.
Eligibility to file a lawsuit is often contingent upon specific criteria, such as experiencing severe complications like mesh erosion, infection, or pain after the mesh implantation.
These lawsuits aim to hold manufacturers accountable for providing defective products that have jeopardized patients’ health.
Individuals seeking to file a vaginal mesh lawsuit in 2025 must meet certain eligibility requirements to proceed with their claims.
These criteria typically include having experienced significant complications arising from the mesh implant, such as erosion, pain, or infection.
Additionally, the timing of the mesh implantation plays a crucial role, as most lawsuits require that the device was implanted before a specific date, often set as December 31, 2021. Proof of medical complications linked directly to the mesh is necessary to support the claims effectively.
Eligibility requirements may include, but are not limited to:
Meeting these criteria positions a potential plaintiff to file a lawsuit against the mesh manufacturers, which involves producing evidence of the suffering caused by the defective product.
Legal proceedings often require thorough documentation of medical history, treatments undergone due to mesh complications, and expert testimonies to substantiate claims.
Prospective claimants are encouraged to consult legal professionals to determine their eligibility and the viability of their cases, reinforcing their efforts to secure compensation for the harms endured.
Participating in vaginal mesh settlements requires claimants to meet specific criteria similar to those needed for filing a lawsuit.
Claimants must have suffered tangible harm or injury due to the mesh device and been part of previous or ongoing litigation.
These settlements offer individuals an opportunity to receive compensation without undergoing a full trial, often based on negotiated terms reflecting the severity of their injuries and the medical expenses incurred.
Claimants eligible for settlements typically include:
Vaginal mesh settlements provide a streamlined resolution for many claimants, offering compensation that reflects both the individual’s injuries and the broader context of their legal actions.
Settlement amounts can vary widely, often depending on the severity of the injuries, the extent of the medical treatments required, and whether the plaintiff was involved in earlier group litigations.
As settlements can provide quicker resolutions than lengthy trials, they remain a favorable option for many plaintiffs seeking justice and financial relief for their suffering.
Transvaginal mesh lawsuits are a significant legal battle involving numerous manufacturers and their alleged negligence.
These lawsuits, filed by women who have experienced severe health complications, focus on issues such as organ perforation, chronic pain, and sexual dysfunction attributed to these medical devices.
The litigation has evolved into multiple multi-district litigations (MDLs) due to the sheer volume of cases against these companies.
While some manufacturers have reached settlements, litigation continues as new cases are filed, reflecting the ongoing nature of these personal injury claims.
Boston Scientific is one of the major manufacturers involved in transvaginal mesh litigation.
Legal actions against the company stem from complications associated with its pelvic mesh products, such as the Obtryx, designed to treat pelvic organ prolapse and stress urinary incontinence.
Many women have reported severe injuries and health complications as a result of these products, leading to numerous lawsuits against Boston Scientific.
These cases have highlighted significant concerns regarding the safety and efficacy of such devices.
Potential settlement amounts and lawsuit details may include:
The magnitude of litigation faced by Boston Scientific underscores the pressure on manufacturers to address these safety concerns.
The company has been part of massive class action lawsuits, contributing to the landscape of transvaginal mesh litigations.
Settlements and verdicts in these cases help victims receive compensation for their suffering, although the legal battles continue.
These proceedings not only impact Boston Scientific but also shape the broader regulatory and legal framework governing medical device safety.
Several other manufacturers besides Boston Scientific have been implicated in transvaginal mesh lawsuits.
Companies such as Johnson & Johnson, C.R.
Bard, and Coloplast face similar legal challenges due to the adverse effects of their pelvic mesh products.
These lawsuits allege that the devices are dangerous and have caused significant harm, prompting a host of legal claims.
As of late, more than 100,000 lawsuits have been filed against various manufacturers, each highlighting serious complications tied to their devices.
The following companies are typically involved:
The involvement of multiple manufacturers demonstrates the widespread issues associated with transvaginal mesh products.
These companies have paid substantial sums in settlements, reflecting the severity of the claims.
Furthermore, the ongoing litigation against these entities has sparked broader discussions about patient safety and regulatory oversight in the medical device industry.
This wave of lawsuits emphasizes the need for stringent testing and clearer warning labels to prevent similar medical tragedies in the future.
As of 2025, transvaginal mesh lawsuits have continued to be a critical issue within the legal and medical communities.
The vast majority of these cases have concluded through settlements, with estimates suggesting over $8 billion paid out by manufacturers historically.
Current speculations propose that new settlements might range from $150,000 to over $400,000 per case, depending on individual circumstances, including the severity of injuries.
These settlements are pivotal in compensating for the suffering and medical costs endured by the claimants.
Projected settlement amounts for transvaginal mesh lawsuits in 2025 are largely influenced by the settlements that have already been achieved in previous years.
With over $8 billion paid in total, individual settlements are anticipated to continue in a substantial monetary range.
Experts suggest that amounts could vary between $150,000 to $450,000 depending on specifics like the individual’s suffering and resultant medical expenses.
These projections highlight the ongoing financial implications faced by manufacturers and underline the potentially significant compensatory relief accessible to victims.
Potential settlement amounts may include, but are not limited to:
Settlement amounts will naturally vary from case to case, factoring in both the physical impact on the plaintiff and the financial burden they have borne.
The wide range between $150,000 and $450,000 reflects the diverse nature of claims, where some cases may involve less severe complications while others require significant ongoing care and financial support.
These compensations play an essential role in addressing the justice and relief sought by plaintiffs, providing a semblance of recovery from the incurred damages.
Several dynamics influence the settlement amounts and payout structures for transvaginal mesh lawsuits in 2025.
Key considerations include the severity of the claimant’s injuries, the necessity for corrective surgeries, and the impact of these injuries on their quality of life.
In addition, legal strategies and the jurisdiction where the case is filed can also dramatically affect settlement outcomes.
These factors collectively guide the determination of settlement values, aiming to equitably compensate victims for their suffering and future implications.
The following factors typically include:
Each factor is assessed meticulously, and the interplay between them can lead to varied payout structures, even among similar cases.
For instance, a case in one jurisdiction might result in a higher settlement due to precedent or particular court tendencies.
Transvaginal mesh lawsuits are being filed by individuals across the country who were injured by these defective medical devices.
TruLaw is currently accepting clients for the transvaginal mesh litigation.
A few reasons to choose TruLaw for your transvaginal mesh lawsuit include:
If you or a loved one suffered mesh erosion, organ perforation, or other complications after being implanted with a transvaginal mesh device, you may be eligible to seek compensation.
Contact TruLaw using the chat on this page to receive an instant case evaluation that can determine if you qualify for the transvaginal mesh litigation today.
Medical literature documents several serious complications arising from transvaginal mesh devices, including erosion through vaginal tissue, organ perforation, and chronic pain.
These adverse events often necessitate revision surgeries and ongoing medical intervention to address both immediate and long-term health impacts.
Transvaginal mesh settlement values typically reflect the severity of complications, number of revision surgeries required, and extent of ongoing medical care needed.
Individual compensation amounts vary based on documented medical expenses, impact on quality of life, and specific device manufacturer involvement.
Specialists assessing transvaginal mesh surgery outcomes examine factors including mesh erosion, organ damage, infection rates, and chronic pain patterns.
Their evaluations provide crucial documentation for both medical treatment planning and potential legal proceedings.
Successful claims typically require comprehensive medical records documenting the initial implant procedure, subsequent complications, and all related medical interventions.
Healthcare providers must maintain detailed documentation of patient symptoms, treatment responses, and ongoing medical needs.
Medical teams must carefully evaluate mesh-related complications to determine appropriate intervention strategies.
Revision procedures often involve complex surgical techniques to address mesh erosion, tissue damage, and associated complications while minimizing additional trauma.
Healthcare providers implement systematic monitoring programs to track potential complications and address emerging health concerns.
Regular assessments include physical examinations, imaging studies, and evaluation of patient-reported symptoms to ensure appropriate medical management.
Managing Attorney & Owner
With over 25 years of legal experience, Jessica Paluch-Hoerman is an Illinois lawyer, a CPA, and a mother of three. She spent the first decade of her career working as an international tax attorney at Deloitte.
In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.
In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share the most reliable, accurate, and up-to-date legal information with our readers!
You can learn more about the Transvaginal Mesh Lawsuit by visiting any of our pages listed below:
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TruLaw, we fiercely combat corporations that endanger individuals’ well-being. If you’ve suffered injuries and believe these well-funded entities should be held accountable, we’re here for you.
With TruLaw, you gain access to successful and seasoned lawyers who maximize your chances of success. Our lawyers invest in you—they do not receive a dime until your lawsuit reaches a successful resolution!
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
AFFF Lawsuit claims are being filed against manufacturers of aqueous film-forming foam (AFFF), commonly used in firefighting.
Claims allege that companies such as 3M, DuPont, and Tyco Fire Products failed to adequately warn users about the potential dangers of AFFF exposure — including increased risks of various cancers and diseases.
Suboxone Tooth Decay Lawsuit claims are being filed against Indivior, the manufacturer of Suboxone, a medication used to treat opioid addiction.
Claims allege that Indivior failed to adequately warn users about the potential dangers of severe tooth decay and dental injuries associated with Suboxone’s sublingual film version.
Social Media Harm Lawsuits are being filed against social media companies for allegedly causing mental health issues in children and teens.
Claims allege that companies like Meta, Google, ByteDance, and Snap designed addictive platforms that led to anxiety, depression, and other mental health issues without adequately warning users or parents.
Transvaginal Mesh Lawsuits are being filed against manufacturers of transvaginal mesh products used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI).
Claims allege that companies like Ethicon, C.R. Bard, and Boston Scientific failed to adequately warn about potential dangers — including erosion, pain, and infection.
Bair Hugger Warming Blanket Lawsuits involve claims against 3M — alleging their surgical warming blankets caused severe infections and complications (particularly in hip and knee replacement surgeries).
Plaintiffs claim 3M failed to warn about potential risks — despite knowing about increased risk of deep joint infections since 2011.
Baby Formula NEC Lawsuit claims are being filed against manufacturers of cow’s milk-based baby formula products.
Claims allege that companies like Abbott Laboratories (Similac) and Mead Johnson & Company (Enfamil) failed to warn about the increased risk of necrotizing enterocolitis (NEC) in premature infants.
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?